{
    "study_accession": "SDY78",
    "actual_completion_date": null,
    "actual_enrollment": 178,
    "actual_start_date": null,
    "age_unit": "Weeks",
    "brief_description": "Assess the immunogenicity and antigenicity of recombinant hemagglutinin proteins produced and purified by various methods",
    "brief_title": "Antigenic and immunogenic properties of recombinant hemagglutinin proteins when produced in various protein expression systems",
    "clinical_trial": "N",
    "condition_studied": "Binding of anti-HA specific antibodies, elicited by vaccination or viral infection, to various recombinant forms of the HA from A/Brisbane/59/07 and B/Florida/04/06",
    "dcl_id": 2,
    "description": "Assess the immunogenicity and antigenicity of recombinant hemagglutinin proteins produced and purified by various methods",
    "doi": "10.21430/M3EER1F151",
    "endpoints": "Various timepoints following immunization and or infection",
    "gender_included": "Female, Male",
    "hypothesis": "Recombinant HA proteins that have been produced under conditions that preserve their biological activity and tertiary structure offer optimal detection of HA-specific responses in common immune assays.",
    "initial_data_release_date": "2013-08-15",
    "initial_data_release_version": "DR3",
    "intervention_agent": "Recombinant Hemagglutinin proteins from  A/Brisbane/59/07 and B/Florida/04/06.  Viruses:  A/Brisbane/59/07 and B/Florida/04/06",
    "latest_data_release_date": "2013-08-15",
    "latest_data_release_version": "DR3",
    "maximum_age": "12",
    "minimum_age": "10",
    "objectives": "Determine the degree of antibody cross-reactivity elicited by vaccination with drifted variant H5 hemagglutinins. Determine the neutralization activity of the antibodies elicited by vaccination. Determine the extent of protection elicited by vacciantion.",
    "official_title": "Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems",
    "sponsoring_organization": "NIAID",
    "target_enrollment": null,
    "workspace_id": 2014,
    "research_focus": [
        "Vaccine Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM555",
            "description": "A/Brisbane/59/07 and B/Florida/04/06",
            "name": "rHA_immunization"
        }
    ],
    "personnel": [
        {
            "first_name": "Felix",
            "last_name": "Santiago",
            "organization": "University of Rochester",
            "role_in_study": "Principal Investigator",
            "site_name": "ROC034"
        }
    ],
    "pubmed": [
        {
            "title": "Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems.",
            "journal": "Vaccine.",
            "month": "Jun",
            "year": "2012",
            "doi": "10.1016/j.vaccine.2012.05.005. Epub 2012 May 15.",
            "pubmed_id": "22609035"
        }
    ],
    "program": [
        {
            "program_name": "NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS)",
            "contract_name": "New York Influenza Center of Excellence"
        }
    ],
    "assay": [
        {
            "measurement_technique": "ELISA",
            "number_of_expsamples": 255
        },
        {
            "measurement_technique": "ELISPOT",
            "number_of_expsamples": 60
        },
        {
            "measurement_technique": "Hemagglutination Inhibition",
            "number_of_expsamples": 154
        }
    ],
    "subject": {
        "race": [
            {
                "race": "White",
                "count": 1
            }
        ],
        "gender": [
            {
                "Male": 1
            }
        ]
    }
}
